We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NUVB Panacea Acquisition Corp

0.04 (3.1%)
Dec 08 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 546,520
Bid Price
Ask Price
News -
Day High 1.35


52 Week Range


Day Low 1.28
Share Name Share Symbol Market Stock Type
Panacea Acquisition Corp NUVB NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
0.04 3.1% 1.33 19:00:00
Open Price Low Price High Price Close Price Previous Close
1.30 1.28 1.35 1.33 1.29
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
2,662 546,520 US$ 1.32 US$ 721,603 - 0.95 - 2.545
Last Trade Type Quantity Price Currency
18:00:00 69,803 US$ 1.33 USD

Panacea Acquisition Corp Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
291.2M 218.94M - 0 -104.2M -0.48 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Panacea Acquisition News

Date Time Source News Article
11/27/202315:09Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
11/27/202315:01Edgar (US Regulatory)Form 8-K - Current report
11/13/202315:11Edgar (US Regulatory)Form 8-K - Current report
11/13/202315:05Business WireNuvation Bio Announces Departure of Chief Financial Officer
11/02/202315:23Edgar (US Regulatory)Form 8-K - Current report
11/02/202315:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202315:10Business WireNuvation Bio Reports Third Quarter 2023 Financial Results..
8/03/202316:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/202315:17Edgar (US Regulatory)Form 8-K - Current report
8/03/202315:10Business WireNuvation Bio Reports Second Quarter 2023 Financial Results..
6/01/202315:05Business WireNuvation Bio Announces Formation of Oncology-Focused..
5/04/202315:05Business WireNuvation Bio Reports First Quarter 2023 Financial Results..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No NUVB Message Board. Create One! See More Posts on NUVB Message Board See More Message Board Posts

Historical NUVB Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.271.381.221.32846,8030.064.72%
1 Month1.241.411.211.291,114,7990.097.26%
3 Months1.381.450.951.201,540,314-0.05-3.62%
6 Months1.782.130.951.34966,397-0.45-25.28%
1 Year1.982.5450.951.54798,441-0.65-32.83%
3 Years10.0015.230.955.26850,376-8.67-86.7%
5 Years10.0015.230.955.26850,376-8.67-86.7%

Panacea Acquisition Description

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |